| abstract |
The invention relates to use of compounds represented by the general formula (I) : and pharmaceutically acceptable salts thereof, wherein n is an integer from 2 to 5; p is an integer from 0 to 4; R1 is independently selected from the group consisting of a hydroxl group, an alkoxy group, a thiol group, and a thioether group, wherein at least two of R1 are on the carbon-2 and carbon-5 positions of the phenyl group; R2 and R3 are independently a methylene group or a nucleophile; Z is an oxygen (O) atom or sulfur (S) atom; and T is hydrogen or an optionally substituted aliphatic group or optionally substituted aryl group; in the manufacture of a medicament for prevention and/or treatment and/or containment of a condition associated with a cell proliferative disorder. Particular conditions include tumorigenesis and cancer. |